Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Intern Med ; 61(19): 2957-2959, 2022 Oct 01.
Article in English | MEDLINE | ID: covidwho-1968933

ABSTRACT

Loss of taste is a relatively common symptom of coronavirus disease 2019 (COVID-19) and has also been considered a rare Guillain-Barré syndrome (GBS) symptom. We herein report a case of a facial diplegia and paresthesia (FDP) variant of GBS that initially presented as a loss of taste occurring two weeks after COVID-19 mRNA vaccination. The patient recovered completely after intravenous immunoglobulin therapy. Clinicians should consider the possibility of post-vaccination FDP manifesting as facial palsy and should be aware that GBS, including the FDP variant, can initially present as an isolated loss of taste.


Subject(s)
Ageusia , COVID-19 , Guillain-Barre Syndrome , Guillain-Barre Syndrome/diagnosis , Guillain-Barre Syndrome/etiology , Humans , Immunoglobulins, Intravenous/therapeutic use , Paresthesia/etiology , RNA, Messenger
SELECTION OF CITATIONS
SEARCH DETAIL